NEWS

Long-Acting Reversible Contraception by Effervescent Microneedle Patch

November 18, 2019

Recently published in Science Advances, “long-acting reversible contraception by effervescent microneedle patch” describes a new contraceptive patch with biodegradable microneedles that release hormones under the skin.

According to the authors from Georgia Tech and the University of Michigan, including Steven Schwendeman, PhD, Chair and Ara G. Paul Professor of Pharmaceutical Sciences, their work aims to increase access to long-acting contraception. The authors have developed a reversible contraceptive microneedle patch that is simple-to-administer, slowly releases contraceptive hormone (levonorgestrel) for >1 month, and generates no biohazardous sharps waste.

After manually pressing the patch to skin for 1 min, microneedles rapidly separate from the patch within the skin due to effervescence triggered by contact with skin’s interstitial fluid, as demonstrated in rats and human participants. Long-acting contraception is achieved by formulating microneedles with a biodegradable polymer [poly(lactic-co-glycolic) acid] that slowly releases levonorgestrel for ~1 month in vitro. In rats, the patch maintained levonorgestrel concentration above the human contraceptive threshold level for >1 month, and a placebo microneedle patch was well-tolerated in human participants.

Women of reproductive age in three continents demonstrated interest in and preference for long-acting contraception by microneedle patch. These studies indicate that an effervescent microneedle patch could facilitate greater access to long-acting contraception.

This research was funded by USAID through a grant to the nonprofit humanitarian development organization FHI 360.

Read the full paper: https://advances.sciencemag.org/content/5/11/eaaw8145.full

SHARE THIS ARTICLE

Latest News

College of Pharmacy Unveils Brand New Website Focused on the Ultimate User Experience

February 27, 2025

The College of Pharmacy has launched a newly designed website aimed at enhancing user experience and telling the story of the College’s top-nationally ranked programs. 

Circular RNA: An Emerging Class of RNA in the Fight Against Cancer and Infectious and Genetic Diseases

February 14, 2025

College of Pharmacy researchers in the lab of Guizhi (Julian) Zhu have developed a promising new weapon in the war on cancer: small circular mRNA vaccines.

Assistant Dean Regina McClinton Awarded with U-M Distinguished Diversity Leaders Award

January 28, 2025

This award recognizes staff members who work toward achieving a welcoming, supportive and inclusive work environment for all, and celebrates those who embrace the value of expanding access to the University of Michigan’s educational opportunities.